AIP
CVS icon

Almanack Investment Partners’s CVS Health CVS Stock Holding History

Almanack Investment Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,948
Closed -$219K – 170
2023
Q1 		$219K Buy
2,948
+75
+3% +$6.29K 0.04% 155
2022
Q4 		$268K Sell
2,873
-803
-22% -$77.5K 0.06% 142
2022
Q3 		$351K Buy
3,676
+203
+6% +$20.1K 0.07% 96
2022
Q2 		$322K Sell
3,473
-617
-15% -$60.2K 0.03% 302
2022
Q1 		$414K Sell
4,090
-536
-12% -$56.3K 0.04% 294
2021
Q4 		$477K Sell
4,626
-90
-2% -$8.32K 0.04% 270
2021
Q3 		$400K Buy
4,716
+603
+15% +$50.5K 0.04% 300
2021
Q2 		$343K Sell
4,113
-2,377
-37% -$195K 0.03% 295
2021
Q1 		$488K Buy
6,490
+1,243
+24% +$90.5K 0.05% 239
2020
Q4 		$358K Buy
5,247
+1,730
+49% +$113K 0.04% 261
2020
Q3 		$247K Buy
+3,517
New +$219K 0.03% 334

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Almanack Investment Partners's CVS Position: Q2 2023 in Review

Almanack Investment Partners sold out of CVS Health (CVS) in Q2 2023, closing a stake of 2,948 shares — an estimated $219K sold.

Almanack Investment Partners first reported a position in CVS in Q3 2020 and held it in 11 quarters. The position peaked at $488K in Q1 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Almanack Investment Partners reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Almanack Investment Partners sold 2,948 CVS Health shares in Q2 2023, an estimated $219K.
  • Almanack Investment Partners first reported a position in CVS Health in Q3 2020 and held it in 11 quarters.
  • Almanack Investment Partners's CVS Health position peaked at $488K in Q1 2021.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Almanack Investment Partners's 13F filing for Q2 2023, filed 8 Aug 2023.